Other researchers used a blocker displacement amplification-derived method as a tool for MRD monitoring, to examine sequential blood samples from an EGFR-mutated NSCLC patient who exhibited no evidence of radiologic recurrence [37]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.